未登录Phase II single-arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated classical Kaposi sarcoma (cKS)nivolumab和ipilimumab (Nivo/Ipi) 在先前治疗的经典卡波西肉瘤 (cKS) 中的II期单臂研究
Zer, A.; Icht, O.; Yosef, L.; Avram, D.; Jacobi, O.; Fenig, E.; Kurman, N.; Peretz, I; Shamai, S.; Merimsky, O.; Ben-Ami, E.; Frommer, R. Shapira; Schwarzbach, A. E.; Bernstine, H.; Weitzen, R.; Vornicova, O.; Bar-Sela, G.; Stemmer, S. M.; Lotem, M. .png)
分享.png)
收藏Ex vivo organotypic cultures for synergistic therapy prioritization identify patient-specific responses to combined MEK and Src inhibition in colorectal cancer用于协同治疗优先化的离体器官型培养物鉴定对结直肠癌中MEK和Src联合抑制的患者特异性反应Gavert, Nancy; Zwang, Yaara; Weiser, Roi; Greenberg, Orli; Halperin, Sharon; Jacobi, Oded; Mallel, Giuseppe; Sandler, Oded; Berger, Adi Jacob; Stossel, Erez; Rotin, Daniil; Grinshpun, Albert; Kamer, Iris; Barzs, Jair; Pines, Guy; Saidian, Daniel; Bar, Ilan; Golan, Shay; Rosenbaum, Eli; Nadu, Andrei; Ben-Ami, Eytan; Weitzen, Rony; Nechushtan, Hovav; Golanz, Talia; Brenner, Baruch; Nissan, Aviram; Margalitzs, Ofer; Hershkovitz, Dov; Lahat, Guy; Straussman, Ravid 分享 收藏 Quantification of human serum procollagen C-proteinase enhancer (hsPCPE) glycopatternOlswang-Kuz, Yael; Liberman, Boaz; Weiss, Israel; Ramu, Eyal; Weitzen, Rony; Vered, Iris; Gat-Yablonski, Galia; Kessler, Efrat; Anikster, Yair; Mesilaty-Gross, Shlomit 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 Targeting pulmonary metastases of renal cell carcinoma by inhalation of interleukin-2Merimsky, O; Gez, E; Weitzen, R; Nehushtan, H; Rubinov, R; Hayat, H; Peretz, T; Ben-Shahar, M; Biran, H; Katsenelson, R; Mermershtein, V; Loven, D; Karminsky, N; Neumann, A; Matcejevsky, D; Inbar, M 分享 收藏 Interleukin-2 improves tumour response to DNP-modified autologous vaccine for the treatment of metastatic malignant melanomaInterleukin-2改善肿瘤对DNP修饰的自体疫苗治疗转移性恶性黑色素瘤的反应Lotem, M; Shiloni, E; Pappo, I; Drize, O; Hamburger, T; Weitzen, R; Isacson, R; Kaduri, L; Merims, S; Frankenburg, S; Peretz, T 分享 收藏 Autologous cell vaccine as a post operative adjuvant treatment for high-risk melanoma patients (AJCC stages III and IV)Lotem, M; Peretz, T; Drize, O; Gimmon, Z; El, DA; Weitzen, R; Goldberg, H; Ben David, I; Prus, D; Hamburger, T; Shiloni, E 分享 收藏 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
